top biopharmaceuticals for glp-1 medication Women with a common hormonal disorder have few good treatment options. Could drugs help? Top 12 Pharma: Pfizer Tops

Oral GLP-1 Formulations and Future Projections Several companies are developing oral GLP-1 formulations, including Novo Nordisk, Pfizer, and smaller firms, positioning them as potential acquisition targets

The Phase III clinical SURMOUNT-1 (NCT04184622) for tirzepatide, is expected to be completed in the first half of 2024

Request Free Sample Speak to Analyst Introduction The Global Glucagon-Like Peptide-1 Agonists Market refers to the pharmaceutical sector involved in the development, production, and commercialization of GLP-1 receptor agonist drugs used primarily for type 2 diabetes and obesity management

The pancreatic lipase inhibitor orlistat loses weight by inhibiting pancreatic lipase activity, which in turn inhibits the breakdown and absorption of fat from food

This data supports the product's launch in 2014 as the first approved GLP-1 weight loss drug

Summary table of the three obesity drugs with levers for ease of use, efficacy, and pricing